讯飞医疗科技股份有限公司是一家主要从事提供人工智能赋能的医疗解决方案的中国公司。基层医疗服 务业务线由智医助理及慢病管理组成。医院服务业务线包括智慧医院解决方案和诊疗助理。患者服务业 务线包括智慧医院患者服务与诊后管理（包括讯飞晓医App及小程序）、影像云平台以及医疗器械。区 域管理平台解决方案业务线包括智慧卫生解决方案和智慧医保。该公司主要在国内市场开展业务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月27日南向资金增持2.6万股讯飞医疗科技（02506.HK）。近5个交易日中，获南向资 金增持的有3天，累计净增持9.85万股。近20个交易日中，获南向资金增持的有11天，累计净增持12.06 万股。截至目前，南向资金持有讯飞医疗科技（02506.HK）523.32万股，占公司已发行普通股的 6.76%。 ...

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 讯飞医疗科技股份有限公司是一家主要从事提供人工智能赋能的医疗解决方案的中国公司。基层医疗服 务业务线由智医助理及慢病管理组成。医院服务业务线包括智慧医院解决方案和诊疗助理。患者服务业 务线包括智慧医院患者服务与诊后管理（包括讯飞晓医App及小程序）、影像云平台以及医疗器械。区 域管理平台解决方案业务线包括智慧卫生解决方案和智慧医保。该公司主要在国内市场开展业务。 证券之星消息，2月26日南向资金减持4000.0股讯飞医疗科技（02506.HK）。近5个交易日中，获南向资 金增持的有3天，累计净增持8.58万股。近20个交易日中，获南向资金增持的有10天，累计净增持5.79万 股。截至目前，南向资金持有讯飞医疗科技（02506.HK）520.72万股，占公司已发行普通股的6.73%。 ...

Core Viewpoint - Southbound funds increased their holdings in iFlytek Medical Technology (02506.HK) by 13,400 shares on February 12, indicating a fluctuating interest from investors in the company [1] Group 1: Southbound Fund Activity - Over the past five trading days, there were three days of net reductions in holdings, totaling a decrease of 227,900 shares [1] - In the last twenty trading days, there were ten days of net increases, with a total increase of 326,000 shares [1] - As of now, southbound funds hold 5,134,800 shares of iFlytek Medical Technology, representing 6.63% of the company's total issued ordinary shares [1] Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services (comprising intelligent medical assistants and chronic disease management), hospital services (including smart hospital solutions and diagnostic assistants), and patient services (such as smart hospital patient services and post-discharge management) [1] - The regional management platform solutions business line includes smart health solutions and smart medical insurance [1]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in iFlytek Medical Technology (02506.HK) by 186,500 shares on February 10, 2026, marking a decrease of 3.44% [1][2] - Over the past five trading days, there have been four days of reductions in holdings, totaling a net decrease of 210,700 shares [1] - In the last 20 trading days, there were 11 days of increased holdings, with a cumulative net increase of 1,308,000 shares [1] Group 2 - As of now, southbound funds hold 5,231,600 shares of iFlytek Medical Technology, which represents 6.76% of the company's total issued ordinary shares [1] - The company primarily engages in providing AI-powered medical solutions, with business lines including grassroots medical services, hospital services, patient services, and regional management platform solutions [2] - The grassroots medical services line consists of intelligent medical assistants and chronic disease management, while the hospital services line includes smart hospital solutions and diagnostic assistance [2]

Core Viewpoint - Southbound funds reduced their holdings in iFlytek Medical Technology (02506.HK) by 9,400 shares on February 5, indicating a potential shift in investor sentiment towards the company [1] Group 1: Southbound Fund Activity - Over the past 5 trading days, there were 2 days of net purchases by southbound funds, totaling an increase of 104,500 shares [1] - In the last 20 trading days, there were 12 days of net purchases, with a cumulative increase of 1,634,000 shares [1] - Currently, southbound funds hold 5,362,600 shares of iFlytek Medical Technology, representing 6.93% of the company's total issued ordinary shares [1] Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services (intelligent medical assistants and chronic disease management), hospital services (smart hospital solutions and diagnostic assistants), and patient services (smart hospital patient services and post-discharge management, including the iFlytek Xiaoyi App and mini-programs) [1] - The regional management platform solutions business line encompasses smart health solutions and smart medical insurance [1] - The company mainly operates in the domestic market [1]

Group 1 - The core viewpoint of the news highlights the performance of the domestic information technology application innovation industry index, which has seen a decline of 0.94% as of 10:45, with mixed results among constituent stocks [1] - The leading stock, Borui Data, increased by 7.92%, while the lagging stock, Fanwei Network, decreased by 4.71% [1] - The Xinchang ETF (562570) has also experienced a decline of 1.47%, with the latest price at 1.48 yuan [1] Group 2 - In terms of liquidity, the Xinchang ETF had a turnover of 4.86% during the trading session, with a transaction volume of 22.07 million yuan [2] - The Xinchang ETF has seen a significant growth in scale over the past week, increasing by 607.49 million yuan, leading its peers [2] - Over the last three days, the Xinchang ETF has experienced continuous net inflows, with a maximum single-day net inflow of 30.00 million yuan, totaling 37.58 million yuan, averaging 12.53 million yuan in daily net inflow [2] Group 3 - Northeast Securities indicates that the information technology application innovation industry is rapidly developing due to a dual drive from policy and market, with the market size reaching 2,096.19 billion yuan in 2023, reflecting a year-on-year growth of 25.6% [3] - A national-level policy framework has been established, consisting of "top-level design - special support - standard specifications" [3] - The information technology application innovation industry encompasses IT infrastructure, basic software, application software, and information security, forming a complete industrial chain and ecosystem [3] - The industry has developed a strategic layout of "2+8+N," covering key sectors such as government, finance, telecommunications, and healthcare, along with various consumer markets [3] - The Xinchang ETF (562570) closely tracks the domestic information technology application innovation index, emphasizing domestic full-stack substitution and integrating key areas such as storage chips, CPUs, and AI applications [3]

Core Viewpoint - The southbound capital has increased its holdings in iFlytek Medical Technology (02506.HK), indicating growing investor interest in the company [1]. Group 1: Shareholding Changes - On January 23, 2026, southbound capital held a total of 5.1505 million shares of iFlytek Medical Technology, with an increase of 37,900 shares, representing a change of 0.74% [2]. - Over the past five trading days, there were two days of net increases in holdings, totaling 36,900 shares [1]. - In the last 20 trading days, there were eight days of net increases, accumulating to 1.1123 million shares [1]. Group 2: Company Overview - iFlytek Medical Technology is primarily engaged in providing AI-powered medical solutions in China, with business lines including grassroots medical services, hospital services, patient services, and regional management platform solutions [2]. - The grassroots medical services include intelligent medical assistants and chronic disease management [2]. - The hospital services encompass smart hospital solutions and diagnostic assistance, while patient services involve smart hospital patient services and post-discharge management [2].

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in iFlytek Medical Technology (02506.HK) by 3,500 shares on January 8, with a total net reduction of 193,900 shares over the last five trading days [1] - Over the past 20 trading days, there have been 11 days of net reductions in southbound fund holdings, totaling 215,500 shares [1] - As of now, southbound funds hold 3,728,700 shares of iFlytek Medical Technology, which represents 4.82% of the company's total issued ordinary shares [1] Group 2 - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services, hospital services, patient services, and regional management platform solutions [1] - The grassroots medical services line consists of intelligent medical assistants and chronic disease management, while the hospital services line includes smart hospital solutions and diagnostic assistance [1]

Core Viewpoint - Neusoft Group has signed a strategic cooperation agreement with Xi'an Jiaotong University First Affiliated Hospital, marking a significant milestone in their 20-year partnership, aimed at advancing smart hospitals and healthcare innovation [1][2] Group 1: Strategic Cooperation - The cooperation will focus on smart hospitals, medical-engineering integration, and innovation in the healthcare industry, evolving from business collaboration to a strategic community [1] - The partnership aims to integrate top medical resources from Xi'an Jiaotong University First Affiliated Hospital with Neusoft's industrial ecosystem and technological R&D capabilities [1] Group 2: Technological Integration - The collaboration will leverage AI and data as core drivers, optimizing medical services through the construction of "four platforms + one system" [1] - The initiative aims to enhance resource sharing, enable precise management, and unlock data value, positioning Xi'an Jiaotong University First Affiliated Hospital as a new benchmark for smart hospitals in China [1] Group 3: Research and Development - A cross-disciplinary research team will be established to focus on integrating medical engineering and information technology, accelerating the transformation of research into practical applications [1] - The partnership will explore innovative services in healthcare, wellness, and education through new technologies [1][2]

Core Viewpoint - Recent trading activity indicates a reduction in holdings by southbound funds in iFlytek Medical Technology, suggesting potential shifts in investor sentiment towards the company [1] Group 1: Trading Activity - On December 22, southbound funds reduced their holdings by 40,900 shares of iFlytek Medical Technology (02506.HK) [1] - Over the past five trading days, there have been four days of net reductions, totaling 107,900 shares [1] - In the last 20 trading days, there were 14 days of net increases, with a total of 91,600 shares added [1] - Currently, southbound funds hold 3,978,600 shares of iFlytek Medical Technology, representing 5.14% of the company's issued ordinary shares [1] Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services (intelligent medical assistants and chronic disease management), hospital services (smart hospital solutions and diagnostic assistants), and patient services (smart hospital patient services and post-diagnosis management) [1] - The company also offers regional management platform solutions, including smart health solutions and smart medical insurance [1] - iFlytek Medical Technology mainly operates in the domestic market [1]